These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 34856682)
1. [Guidelines on the management of cholestasis liver diseases (2021)]. Chinese Society of Hepatology, Chinese Medical Association Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1075-1087. PubMed ID: 34856682 [TBL] [Abstract][Full Text] [Related]
2. [Guidelines on the management of cholestasis liver diseases (2021)]. Chinese Society of Hepatology, Chinese Medical Association Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):253-263. PubMed ID: 35462480 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for the Management of Cholestatic Liver Diseases (2021). Lu L; J Clin Transl Hepatol; 2022 Aug; 10(4):757-769. PubMed ID: 36062287 [TBL] [Abstract][Full Text] [Related]
4. Cholestatic and metabolic liver diseases: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Thompson RJ; Azevedo RA; Galoppo C; Lewindon P; McKiernan P; J Pediatr Gastroenterol Nutr; 2004 Jun; 39 Suppl 2():S611-5. PubMed ID: 15184760 [No Abstract] [Full Text] [Related]
5. [Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)]. Chinese Society of Hepatology, Chinese Medical Association Zhonghua Nei Ke Za Zhi; 2021 Dec; 60(12):1050-1074. PubMed ID: 34856681 [TBL] [Abstract][Full Text] [Related]
6. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Fawaz R; Baumann U; Ekong U; Fischler B; Hadzic N; Mack CL; McLin VA; Molleston JP; Neimark E; Ng VL; Karpen SJ J Pediatr Gastroenterol Nutr; 2017 Jan; 64(1):154-168. PubMed ID: 27429428 [TBL] [Abstract][Full Text] [Related]
7. [The management of autoimmune liver diseases: from the consensus to the guideline]. Ma X Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):3-4. PubMed ID: 26983383 [TBL] [Abstract][Full Text] [Related]
8. UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER. Couto CA; Terrabuio DRB; Cançado ELR; Porta G; Levy C; Silva AEB; Bittencourt PL; ; Carvalho Filho RJ; Chaves DM; Miura IK; Codes L; Faria LC; Evangelista AS; Farias AQ; Gonçalves LL; Harriz M; Lopes EPA; Luz GO; Oliveira PMC; Oliveira EMG; Schiavon JLN; Sevá-Pereira T Arq Gastroenterol; 2019 Aug; 56(2):232-241. PubMed ID: 31460591 [TBL] [Abstract][Full Text] [Related]
9. EASL Clinical Practice Guidelines on genetic cholestatic liver diseases. European Association for the Study of the Liver J Hepatol; 2024 Aug; 81(2):303-325. PubMed ID: 38851996 [TBL] [Abstract][Full Text] [Related]
10. Medical management of chronic cholestatic liver diseases. Gossard AA; Lindor KD Can J Gastroenterol; 2000 Nov; 14 Suppl D():93D-98D. PubMed ID: 11110620 [TBL] [Abstract][Full Text] [Related]
11. [Explanation of the 2013 Chinese expert consensus guidelines for the diagnosis and treatment of cholestatic liver disease]. Xie W; Cheng J Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):20-3. PubMed ID: 24754086 [No Abstract] [Full Text] [Related]
12. [Chinese expert consensus guidelines for the diagnosis and treatment of cholestatic liver disease reached in 2013]. Chinese Expert Committee on the Diagnosis and Treatment of Cholestasis Liver Disease Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):9-19. PubMed ID: 24754085 [No Abstract] [Full Text] [Related]
13. [Consensus on the diagnosis and treatment of cholestasis liver diseases]. ; ; ; Lu LG Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):924-33. PubMed ID: 26739466 [No Abstract] [Full Text] [Related]
14. Cholestatic liver diseases in adults. McGill JM; Kwiatkowski AP Am J Gastroenterol; 1998 May; 93(5):684-91. PubMed ID: 9625109 [TBL] [Abstract][Full Text] [Related]
15. [Update points for the 2022 edition of the European Association for the Study of Liver Diseases Clinical Practice Guidelines for the Management of Hepatic Encephalopathy and comparison with China's 2018 edition guidelines]. Zhang TY; Sun X; Yao YH; Jin Q; Gan DN; Ye YA; Li XK Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):921-927. PubMed ID: 37872087 [TBL] [Abstract][Full Text] [Related]
16. Cholestatic liver disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Suchy FJ; Burdelski M; Tomar BS; Sokol RJ J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 2():S89-97. PubMed ID: 12192176 [No Abstract] [Full Text] [Related]
17. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Moyer V; Freese DK; Whitington PF; Olson AD; Brewer F; Colletti RB; Heyman MB; J Pediatr Gastroenterol Nutr; 2004 Aug; 39(2):115-28. PubMed ID: 15269615 [TBL] [Abstract][Full Text] [Related]
18. [Guidelines on the diagnosis and management of primary biliary cholangitis (2021)]. Chinese Society of Hepatology, Chinese Medical Association Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):264-275. PubMed ID: 35462481 [TBL] [Abstract][Full Text] [Related]
19. [Expert consensus on diagnosis and treatment of Alagille syndrome associated liver disease (2024)]. ; ; Zhonghua Er Ke Za Zhi; 2024 Aug; 62(8):706-714. PubMed ID: 39039871 [TBL] [Abstract][Full Text] [Related]
20. Cholestatic liver disease. Gossard AA; Talwalkar JA Med Clin North Am; 2014 Jan; 98(1):73-85. PubMed ID: 24266915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]